Cargando…

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk

AIMS : Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC) treatment have relied on data from the early years of NOAC availability. We aimed to study long-term adherence and persistence with NOACs and their association with stroke risk. METHODS AND RESULTS : From the St...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komen, Joris J, Heerdink, Eibert R, Klungel, Olaf H, Mantel-Teeuwisse, Aukje K, Forslund, Tomas, Wettermark, Björn, Hjemdahl, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117431/ https://www.ncbi.nlm.nih.gov/pubmed/32324233 http://dx.doi.org/10.1093/ehjcvp/pvaa017

Ejemplares similares

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study( )
por: Komen, Joris J, et al.
Publicado: (2022)

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality
por: Komen, Joris J, et al.
Publicado: (2019)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care
por: Forslund, Tomas, et al.
Publicado: (2011)

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
por: Farinha, José Maria, et al.
Publicado: (2022)

Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
por: Banerjee, Amitava, et al.
Publicado: (2020)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study
por: Komen, Joris J., et al.
Publicado: (2021)

Erratum to: Long-term adherence and persistence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Publicado: (2021)

Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
por: Jankowska-Polańska, Beata, et al.
Publicado: (2016)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana
por: Ankrah, Daniel NA, et al.
Publicado: (2016)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Suicide Behavior Before and After the Start with Antidepressants: A High Persistent Risk in the First Month of Treatment Among the Young
por: Termorshuizen, Fabian, et al.
Publicado: (2015)

The importance of adherence and persistence in the elderly atrial fibrillation patient
por: Hylek, Elaine M
Publicado: (2020)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal
por: Lowres, Nicole, et al.
Publicado: (2019)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

They promised this ten years ago. Effects of diabetes news characteristics on patients’ perceptions and attitudes towards medical innovations and therapy adherence
por: Vehof, Hans, et al.
Publicado: (2021)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study
por: Rustem Gulluoglu, Fatma, et al.
Publicado: (2020)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Assessing Adherence and Persistence to Non-vitamin K Antagonist Oral Anticoagulants (NOACs) among Patients with Atrial Fibrillation in Tertiary-care Referral Centers in Malaysia
por: Kubas, Mohammed A, et al.
Publicado: (2020)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
por: Song, Ting, et al.
Publicado: (2021)

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation
por: Yang, Lanting, et al.
Publicado: (2021)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda Denise, et al.
Publicado: (2019)

Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
por: Karlsson Lind, Linnéa, et al.
Publicado: (2018)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aeccfnh7detg60stttrhq84lop